Literature DB >> 10627527

Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.

R Welker1, H Hohenberg, U Tessmer, C Huckhagel, H G Kräusslich.   

Abstract

Mature human immunodeficiency virus type 1 (HIV-1) particles contain a cone-shaped core structure consisting of the internal ribonucleoprotein complex encased in a proteinaceous shell derived from the viral capsid protein. Because of their very low stability after membrane removal, HIV-1 cores have not been purified in quantities sufficient for structural and biochemical analysis. Based on our in vitro assembly experiments, we have developed a novel method for isolation of intact mature HIV-1 cores. Concentrated virus suspensions were briefly treated with nonionic detergent and immediately centrifuged in a microcentrifuge for short periods of time. The resuspended pellet was subsequently analyzed by negative-stain and thin-section electron microscopy and by immunoelectron microscopy. Abundant cone-shaped cores as well as tubular and aberrant structures were observed. Stereo images showed that core structures preserved their three-dimensional architecture and exhibited a regular substructure. Detailed analysis of 155 cores revealed an average length of ca. 103 nm, an average diameter at the base of ca. 52 nm, and an average angle of 21.3 degrees. There was significant variability in all parameters, indicating that HIV cores are not homogeneous. Immunoblot analysis of core preparations allowed semiquantitative estimation of the relative amounts of viral and cellular proteins inside the HIV-1 core, yielding a model for the topology of various proteins inside the virion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627527      PMCID: PMC111451          DOI: 10.1128/jvi.74.3.1168-1177.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A.

Authors:  M Grättinger; H Hohenberg; D Thomas; T Wilk; B Müller; H G Kräusslich
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

2.  Characterization of HIV replication complexes early after cell-to-cell infection.

Authors:  L Karageorgos; P Li; C Burrell
Journal:  AIDS Res Hum Retroviruses       Date:  1993-09       Impact factor: 2.205

3.  High-pressure freezing of cell suspensions in cellulose capillary tubes.

Authors:  H Hohenberg; K Mannweiler; M Müller
Journal:  J Microsc       Date:  1994-07       Impact factor: 1.758

4.  Functional association of cyclophilin A with HIV-1 virions.

Authors:  M Thali; A Bukovsky; E Kondo; B Rosenwirth; C T Walsh; J Sodroski; H G Göttlinger
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

5.  Determination of the size of HIV using adenovirus type 2 as an internal length marker.

Authors:  M Gentile; T Adrian; A Scheidler; M Ewald; F Dianzani; G Pauli; H R Gelderblom
Journal:  J Virol Methods       Date:  1994-06       Impact factor: 2.014

6.  Localization of viral protein X in simian immunodeficiency virus macaque strain and analysis of its packaging requirements.

Authors:  V Liska; D Spehner; M Mehtali; D Schmitt; A Kirn; A M Aubertin
Journal:  J Gen Virol       Date:  1994-11       Impact factor: 3.891

7.  Specific incorporation of cyclophilin A into HIV-1 virions.

Authors:  E K Franke; H E Yuan; J Luban
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

8.  Assembly and analysis of conical models for the HIV-1 core.

Authors:  B K Ganser; S Li; V Y Klishko; J T Finch; W I Sundquist
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

9.  The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.

Authors:  N K Heinzinger; M I Bukrinsky; S A Haggerty; A M Ragland; V Kewalramani; M A Lee; H E Gendelman; L Ratner; M Stevenson; M Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

10.  Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy.

Authors:  J J Wang; Y Lu; L Ratner
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

View more
  109 in total

1.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes.

Authors:  L S Ehrlich; T Liu; S Scarlata; B Chu; C A Carter
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

3.  Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag).

Authors:  Y Jenkins; O Pornillos; R L Rich; D G Myszka; W I Sundquist; M H Malim
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Structural organization of authentic, mature HIV-1 virions and cores.

Authors:  John A G Briggs; Thomas Wilk; Reinhold Welker; Hans-Georg Kräusslich; Stephen D Fuller
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

5.  Nucleic acid-independent retrovirus assembly can be driven by dimerization.

Authors:  Marc C Johnson; Heather M Scobie; Yu May Ma; Volker M Vogt
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly.

Authors:  Barbie K Ganser; Anchi Cheng; Wesley I Sundquist; Mark Yeager
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

7.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  The cellular protein lyric interacts with HIV-1 Gag.

Authors:  Christine E Engeland; Heike Oberwinkler; Michael Schümann; Eberhard Krause; Gerd A Müller; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

9.  Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.

Authors:  Minoru Tobiume; Janet E Lineberger; Christopher A Lundquist; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.